EFFECT OF PROTEIN AND PEPTIDE INHIBITORS ON THE ACTIVITY OF PROTEIN DISULFIDE ISOMERASE

被引:89
|
作者
MORJANA, NA [1 ]
GILBERT, HF [1 ]
机构
[1] BAYLOR UNIV,VERNA & MARRS MCLEAN DEPT BIOCHEM,HOUSTON,TX 77030
关键词
D O I
10.1021/bi00234a021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein disulfide isomerase catalyzed reduction of insulin by glutathione is inhibited by peptides of various length and amino acid composition. Peptide inhibitors are competitive against insulin and noncompetitive against GSH, consistent with a sequential rather than a double displacement mechanism. Peptides of unrelated primary sequence that do not contain cysteine inhibit the GSH-insulin transhydrogenase activity of PDI, and the affinity of these peptides toward the enzyme is largely dependent on the peptide length rather than composition, hydrophobicity, or charge. Cysteine-containing peptides are 4-8-fold better inhibitors than non-cysteine-containing peptides of the same length, suggesting a cysteine-specific component to the interaction with the enzyme. Oxidized insulin chain B also inhibits the oxidative folding of reduced ribonuclease in a glutathione redox buffer with an inhibition constant that is comparable to that observed for the inhibition of insulin reduction, suggesting a similar if not identical binding site for the catalysis of oxidative protein folding and the reduction of insulin.
引用
收藏
页码:4985 / 4990
页数:6
相关论文
共 50 条
  • [1] Peptide disulfide RKCGCFF facilitates oxidative protein refolding by mimicking protein disulfide isomerase
    Liu, Hu
    Dong, Xiao-Yan
    Sun, Yan
    BIOCHEMICAL ENGINEERING JOURNAL, 2013, 79 : 29 - 32
  • [2] DsbG, a protein disulfide isomerase with chaperone activity
    Shao, F
    Bader, MW
    Jakob, U
    Bardwell, JCA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) : 13349 - 13352
  • [3] Aldosterone and Protein Disulfide Isomerase Activity in Diabetes
    Romero, Sebastian J.
    Inostroza, Yaritza
    Rivera, Alicia
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [4] The Role of Protein Disulfide Isomerase Inhibitors in Cancer Therapy
    Nie, Qiuying
    Yang, Junwei
    Zhou, Xiedong
    Li, Na
    Zhang, Junmin
    CHEMMEDCHEM, 2025, 20 (01)
  • [5] A mutant protein disulfide isomerase with no chaperone activity
    Dai, Y
    Wang, CC
    FASEB JOURNAL, 1997, 11 (09): : A903 - A903
  • [6] Effect of protein disulfide isomerase chaperone activity inhibition on tissue factor activity
    Raturi, A.
    Ruf, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (08) : 1863 - 1865
  • [7] Protein disulfide isomerase
    Wilkinson, B
    Gilbert, HF
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1699 (1-2): : 35 - 44
  • [8] Protein disulfide isomerase
    Gilbert, HF
    MOLECULAR CHAPERONES, 1998, 290 : 26 - 50
  • [9] A high-throughput turbidometric assay for sereening inhibitors of protein disulfide isomerase activity
    Smith, AM
    Chan, J
    Oksenberg, D
    Urfer, R
    Wexler, DS
    Ow, A
    Gao, LP
    McAlorum, A
    Huang, SG
    JOURNAL OF BIOMOLECULAR SCREENING, 2004, 9 (07) : 614 - 620
  • [10] Design, synthesis and evaluation of protein disulfide isomerase inhibitors with nitric oxide releasing activity
    Li, Lin
    Liu, Jian
    Ding, Yaqi
    Shi, Zhenxiong
    Peng, Bo
    Yang, Naidi
    Hong, Danqi
    Zhang, Chengwu
    Yao, Chuanhao
    Ge, Jingyan
    Huang, Wei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (03)